Counterfeit Bulk Drugs: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, Second Session, June 8 and October 3, 2000, Volume 4
U.S. Government Printing Office, 2000 - Counterfeits and counterfeiting - 423 pages
72 pages matching reports in this book
Results 1-3 of 72
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
adverse events Agency Agency's approved authentic Baker Bliley Burr CDER certificates of analysis Chairman China Commissioner Committee companies compliance counterfeit bulk drugs counterfeit drugs counterfeit pharmaceutical Criminal Investigations Cytotec database detect developed Dingell documents domestic dosage form Drug Administration drug imports drug listing drug products enforcement entry Evaluation FDA's FEII FEIt finished dosage finished drug Flavine Food and Drug foreign inspections Forensic Chemistry Fred Upton gentamicin sulfate Henney human drug identified import alert import inspectors imported counterfeit India industry issue labeling letter Long March manufacturing practices medicines mifepristone misoprostol OASIS pharmaceutical products pharmacies potential prescription drugs problem record regulatory reimportation reports requirements safety samples shipments shipped specific Strickland Stupak substandard surveillance testing tion U.S. agent U.S. Customs Service uaaq unapproved United